Galenica investor relations
WebAug 4, 2016 · Galenica Group today announced that its indirect wholly owned subsidiary, Vifor Pharma USA Inc., is commencing today its previously announced tender offer for WebMedia & Investor Relations, Relypsa: Charlotte Arnold, Vice President, Corporate Communications & Investor Relations: Subject : Galenica to acquire Relypsa to …
Galenica investor relations
Did you know?
WebDec 31, 2024 · Galenica achieves sales of more than CHF 4 billion for the first time. With an increase in sales of 4.7% to CHF 4,014.3 million and an adjusted 1 EBIT of CHF 200.8 … WebSep 2, 2016 · Galenica Ltd. P.O. Box · Untermattweg 8 · CH-3001 Bern Phone +41 58 852 85 17 · Fax +41 58 852 85 58 [email protected] · www.galenica.com The Galenica …
WebIntuitive ISRG for Investors WebAug 4, 2016 · Galenica Group today announced that its indirect wholly owned subsidiary, Vifor Pharma USA Inc., is commencing today its previously announced tender offer for any and all outstanding shares of common stock ...
WebThe fifth Annual General Meeting of Galenica Ltd. was held on 11 May 2024 – with shareholders actually in attendance for the first time in two years – at the Kursaal in … WebJul 21, 2016 · Galenica Investor Relations: Jörg Kneubühler, Chief Financial Officer ... Charlotte Arnold, Vice President, Corporate Communications & Investor Relations Tel.: +1 650 421 9352
WebGalenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and ...
WebApr 12, 2024 · Il Consiglio di Amministrazione propone la convocazione dell’Assemblea Straordinaria degli Azionisti, avente all’ordine del giorno: 1. Modifica dell’articolo 6 (Capitale sociale) al fine di introdurre una nuova categoria di azioni denominata “Azioni Speciali cum warrant” a servizio dell’integrale conversione delle obbligazioni convertibili “Enertronica … pascal proton apicilWebGalenica is the leading fully integrated healthcare provider in Switzerland and plays a key role in the Swiss healthcare market. We want to sustainably and successfully strengthen … pascal prot rtlWebFind company research, competitor information, contact details & financial data for GALENICA S.A. of Kifissia. Get the latest business insights from Dun & Bradstreet. pascal puigWebJan 21, 2024 · Investor Relations Media Felix Burkhard Christina Hertig CFO Galenica Head Corporate Communication Tel.: +41 58 852 85 29 Tel.: +41 58 852 85 17 Mail: … pascal prottWebAnnual report 2024: Galenica is still growing strongly. With an increase in sales of 4.7% to CHF 4,014.3 million and an adjusted EBIT of CHF 200.8 million (-5.8%), Galenica achieved very good results. Annual report 2024. pascal protonWebApr 21, 2024 · Galenica AG published this content on 21 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and … pa scalp\u0027sWebMar 7, 2024 · Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own … pascal protiere